Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000457758 | SCV000559605 | benign | Wilms tumor 1 | 2024-12-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001692136 | SCV001912919 | benign | not provided | 2020-06-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002418462 | SCV002676480 | benign | Inborn genetic diseases | 2017-09-06 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV001692136 | SCV005279554 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003970335 | SCV004784576 | likely benign | GPC3-related disorder | 2022-05-27 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |